Change in FVC and survival in chronic fibrotic hypersensitivity pneumonitis.

Abstract

The predictive value of the decline in FVC by ≥10% on survival in patients with fibrotic hypersensitivity pneumonitis is unknown. Of 112 patients included, 66 (59%) had surgical lung biopsies. Patients with ≥10% decline in predicted FVC after 6-12 months had a significantly increased risk of all-cause mortality (median survival 53 months, 95% CI 37 to 69 vs… (More)
DOI: 10.1136/thoraxjnl-2017-210035

Topics

Cite this paper

@article{Gimenez2017ChangeIF, title={Change in FVC and survival in chronic fibrotic hypersensitivity pneumonitis.}, author={Andr{\'e}a Gimenez and Karin Mueller Storrer and Lilian Tiemi Kuranishi and Maria Raquel Soares and Rimarcs Gomes Ferreira and Carlos Alberto de Castro Pereira}, journal={Thorax}, year={2017} }